Literature DB >> 7249531

Role of the malate--aspartate shuttle in renal sodium transport in the rat.

B Ross, P Silva, S Bullock.   

Abstract

1. Experiments were designed to establish the relationship between renal gluconeogenesis and sodium transport. Six inhibitors of gluconeogenesis, with different sites of action, were tested in the isolated perfused rat kidney in which renal function, and in particular Na+ reabsorption, was followed. 2. In kidneys from fed or starved rats specific inhibitors of gluconeogenesis neither inhibited nor stimulated Na+ reabsorption; gluconeogenesis and sodium reabsorption are therefore independent of one another under these conditions. 3. Inhibitors of transaminase or malic dehydrogenase inhibited gluconeogenesis from lactate and pyruvate respectively; the transaminase inhibitor significantly inhibited oxidation of lactate and glucose. 4. Sodium reabsorption was inhibited by a transaminase inhibitor when glucose or lactate was the sole substrate, and by inhibition of malic dehydrogenase when pyruvate was the substrate. 5. These results indicate that the malate--aspartate shuttle controls Na+ reabsorption in the intact kidney by regulating substrate oxidation (and the provision of energy) rather than by any direct involvement of gluconeogenesis in Na+ transport.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249531     DOI: 10.1042/cs0600419

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  2 in total

1.  Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate beta-lyase reactions.

Authors:  Arthur J L Cooper; Sam A Bruschi; Ana Iriarte; Marino Martinez-Carrion
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

2.  Effect of gentamicin-induced nephrotoxicity on some carbohydrate metabolic pathways in the rat renal cortex.

Authors:  A A Abdel-Gayoum; B H Ali; K M Abdel-Razig; A A Bashir; K Ghywarsha
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.